GUZMAN-PEREZ, Angel,QIAN, Wenyuan,MINATTI, Ana Elena,LOW, Jonathan, D.,ALLEN, Jennifer, R.,AMEGADZIE, Albert,BROWN, James,FROHN, Michael, J.,HARRINGTON, Paul, E.,LOPEZ, Patricia,MA, Vu Van,NISHIMURA,
申请号：
TN2015000382
公开号：
TN2015000382A1
申请日:
2015.08.31
申请国别(地区):
TN
年份:
2017
代理人:
摘要：
The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula I wherein variables A4, A5, A6, A8, each of Ra, Rb, R1, R2, R3 and R7 of Formula I, independently, are defined herein. The invention also provides pharmaceutical compositions comprising the compounds, and uses of the compounds and compositions for treatment of disorders and/or conditions related to A-beta plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer's Disease, cognitive deficits, cognitive impairments, schizophrenia and other central nervous system conditions. The invention further provides compounds of Formulas II and III, and sub-formula embodiments thereof, intermediates and methods for preparing compounds of the invention.
